CONMED
CNMD
265 hedge funds and large institutions have $4.55B invested in CONMED in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 100 increasing their positions, 87 reducing their positions, and 27 closing their positions.
19% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 27
15% more repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 87
11% more capital invested
Capital invested by funds: $4.11B → $4.55B (+$440M)
1.78% more ownership
Funds ownership: 108.17% → 109.95% (+1.8%)
1% more funds holding
Funds holding: 262 → 265 (+3)
6% less call options, than puts
Call options by funds: $23.2M | Put options by funds: $24.6M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$44.2M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$40.9M |
| 3 |
BlackRock
New York
|
+$22.3M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$19.2M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$14.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIG
DeepCurrents Investment Group
New York
|
-$19.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$17.1M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$16.3M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$14.5M |
| 5 |
EARNEST Partners
Atlanta,
Georgia
|
-$11.9M |
CNMD Hedge Fund Activity: Q4 2021 in Review
265 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q4 2021, worth a combined $4.55B — up 11% from $4.11B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new CNMD positions and 27 closed out — a net gain of 5 holders — while 100 added to existing stakes and 87 trimmed.
The largest buyer was Jennison Associates, opening a new position worth an estimated $44.2M. The largest seller was DeepCurrents Investment Group, exiting entirely with an estimated $19.9M sold.
- 265 institutional investors held CONMED (CNMD) as of Q4 2021, up from 262 in Q3 2021.
- Funds reported $4.55B of CONMED stock for Q4 2021, up 11% quarter-over-quarter.
- 32 funds opened new CONMED positions in Q4 2021 and 27 closed out, a net change of +5 holders.
- The largest CONMED buyer in Q4 2021 was Jennison Associates, an estimated $44.2M added.
- The largest CONMED seller in Q4 2021 was DeepCurrents Investment Group, an estimated $19.9M sold.
Based on aggregated 13F filings for Q4 2021.